首页> 外文期刊>Current Cancer Therapy Reviews >Editorial (Hot Topic: Ductal Carcinoma in situ (DCIS) of the Breast, Biomarkers, Diagnosis, and Treatment of the Disease)
【24h】

Editorial (Hot Topic: Ductal Carcinoma in situ (DCIS) of the Breast, Biomarkers, Diagnosis, and Treatment of the Disease)

机译:社论(热门话题:乳腺导管原位癌(DCIS),生物标志物,诊断和治疗)

获取原文
获取原文并翻译 | 示例
           

摘要

The incidence of ductal carcinoma in-situ (DCIS) has been steadily increasing recently largely due to the more advancednage of our population, implementation of the mammogram screening program and technological improvements in diagnosticnmammography. Although it has been known to be a potential cancer precursor for a long time, more and more studies havenshown that not all DCIS are alike and DCIS are highly heterogeneous lesions with variable radiographic and histologic morphologynand biologic behavior.
机译:导管原位癌(DCIS)的发病率最近一直在稳步上升,这主要归因于我们人口的先进程度,乳房X线照片筛查计划的实施以及诊断性X线照片的技术进步。尽管很长一段时间以来就知道它是潜在的癌症前体,但越来越多的研究表明,并非所有的DCIS都一样,而且DCIS是高度异质性的病变,其放射学和组织学形态以及生物学行为均不相同。

著录项

  • 来源
    《Current Cancer Therapy Reviews》 |2012年第3期|p.161|共1页
  • 作者

    Paul J. Zhang;

  • 作者单位

    Professor of Pathology and Laboratory Medicine Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania USA.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号